about
Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist.Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationshipAutomated synthesis of backbone protected peptides.Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2.A backbone amide protecting group for overcoming difficult sequences and suppressing aspartimide formationDesign of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus.Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidatesVaccine delivery utilizing liposaccharidesDesign of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligandSimple synthetic toll-like receptor 2 ligandsAuxiliary-assisted chemical ubiquitylation of NEMO and linear extension by HOIP
P50
Q33961477-745CD4D8-EF74-4DE6-A300-176DEC858F0BQ34131142-BAA85B4C-2E52-4C54-9C2B-46A3FCEF8B6DQ34164832-2A56B9C7-4485-43AC-9E65-7E84B3F9D74BQ39756528-D5D2EF61-8AE9-4EAB-9726-2037480D23F9Q41531093-5F17EA90-C65D-49E2-9A7C-52B9B934B7E8Q42845035-0B0FDDA4-985D-442E-80B1-8B83A8067056Q44434190-E1598CF9-992D-43FB-9C7A-D84EC600D330Q46669936-76232D2F-4F89-4E56-859A-E2B6261F43D8Q46751101-2334B41E-3D3F-47E7-B99B-B2633A25D689Q80179308-021FCA24-A758-4CC6-B72B-97FFAC913517Q83740855-41BF0583-A56A-444C-8D7A-BF766DF5176EQ84576735-87FDF977-46EF-4B76-9F2E-BDDB6F554852Q84797420-47399D93-F473-44E7-8C3D-F1DE0498B96BQ92671206-1459332B-0B02-4A0E-BFBF-7E3C853C2F6D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1759-5090
@en
name
Abu-Baker M Abdel-Aal
@ast
Abu-Baker M Abdel-Aal
@en
Abu-Baker M Abdel-Aal
@es
Abu-Baker M Abdel-Aal
@nl
type
label
Abu-Baker M Abdel-Aal
@ast
Abu-Baker M Abdel-Aal
@en
Abu-Baker M Abdel-Aal
@es
Abu-Baker M Abdel-Aal
@nl
prefLabel
Abu-Baker M Abdel-Aal
@ast
Abu-Baker M Abdel-Aal
@en
Abu-Baker M Abdel-Aal
@es
Abu-Baker M Abdel-Aal
@nl
P106
P1153
23134810500
P31
P496
0000-0003-1759-5090